Nurix Therapeutics, Inc. (NRIX) Presents At Baird Global Healthcare Conference 2025 (Transcript)

Question-and-Answer SessionArthur SandsCEO, President & Director Well, thank you for having us. Happy to give you an introduction. These are our disclaimers. So yes, targeted protein degradation is a new field still, although we've been at it for over 10 years. We're based in San Francisco and the Bay Area based on science out of UCSF and Berkeley. And what's pictured on the slide is this evolution of new therapeutic modalities. So we are in targeted protein degradation, which focuses on the removal of prot ...